Moreover, ATP content and MMP were increased, whereas MitoSOX levels were decreased in the Lv5‐SIRT2‐HG+CCM group compared with the HG+CCM group (Figure 6H–J). The gene discussed is SIRT2; the disease is cerebral cavernous malformation.